T Cell repertoire and autoimmunity in multiple sclerosis patients in Sardinia by Liu, Yisu
XXXI CICLO 
T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia 
DEPARTMENT OF BIOMEDICAL SCIENCES 
Director: Prof. Sechi Leonardo Antonio 
Liu Yisu 
Ph.D. Course in Life Sciences and Biotechnologies 
Supervisors: Prof. Sechi Leonardo Antonio 
Dependent of Biomedical Sciences University of Sassari 
Prof. David Kelvin 
Division of Immunology, International Institute of Infection and Immunity 
Shantou University Medical College 
A Thesis in the Field of Biology 
for the Degree of PhD 
Sassari University 
November 2018 
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
Copyright 2018 LiuYisu 
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
Abstract 
Multiple sclerosis (MS) is an autoimmune disease characterized by destruction of 
the myelin sheath and axon loss within the central nervous system. Sardinia is a high-risk 
area of MS(multiple sclerosis). A genetically homogeneous population resulting from 
geographical isolation may be a critical factor that contributes to the high prevalence of 
the MS in Sardinia. It has been found that specific HLA genotypes in the Sardinian 
population are highly correlated with MS. The mechanism of how HLA impacts the 
adaptive immune response and triggers autoimmunity in the MS patient remains 
unknown. The total clonotypes of TCRs in one individual at a given time point is known 
as the T-Cell Receptor repertoire. By using next-generation sequencing, we have 
identified the TCR repertoire of MS patients in Sardinia, Italy. We found that MS patients 
have different TCR repertoires compared to those of healthy controls. MS-associated 
CDR3 sequences have been screened out in this study. BMLF-1 associated CDR3 are 
screened out in the MS-associated CDR3, indicating a higher activity of EBV in MS 
patients. TRBV20.1$TRBJ2.1 and TRBV20.1$TRBJ1.5 and other V-J recombinations 
show significant increases in MS individuals. These results suggest that the TCR 
repertoire may be a promising diagnostic method for disease status in MS patients. V-J 
recombination may be a biomarker for MS, especially in Sardinian people.
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APC Antigen-presenting cell 
BBB  Blood-brain barrier 
CDR3 Complementarity determining region 3 
CDR3-LD  Complementarity determining region 3 length distribution 
CNS Central Nervous System 
CSF  Cerebrospinal fluid 
DCs Dendritic cells 
EAE Experimental autoimmune encephalomyelitis 
EBNA Epstein-Barr Virus nuclear antigen-1 
EBV  Epstein-Barr Virus 
FACS  Fluorescence-activated cell sorting 
HA Haemagglutinin 
HSV Human herpesvirus 
HIV  Human immunodeficiency virus 
HLA  Human leucocyte antigen 
HSCs  Haematopoietic stem cells 
IMGT  International ImMunoGeneTics 
MAG  Myelin-associated glycoprotein 
MAIT  Mucosal-associated invariant T cells 
MBP  Myelin basic protein 
MOG  Myelin oligodendrocyte glycoprotein 
MR1  Major histocompatibility complex class I related protein I 
MS  Multiple sclerosis 
OND  Other neurological disorders 
PBMC  Peripheral blood mononuclear cells 
PCR  Polymerase chain reaction 
PLP  Proteolipid protein 
pMHC  Peptide/MHC 
PPMS  Primary progressive Multiple sclerosis 
RRMS  Relapsing-remitting Multiple sclerosis 
RT-PCR  Reverse transcription polymerase chain reaction 
TCR  T cell receptor 
TCRVa Alpha chain of T cell receptor 
TCRVb Beta chain of T cell receptor 
Th1  T helper 1 cells 
Th7  T helper 7 cells 
Tregs  Regulatory T cells 
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1.1 The Immune System 
The immune system can be divided into two subsystems based on their immunological 
roles and functions, the innate immune system and the adaptive immune system. Innate 
immunity or non-specific immunity is the nonspecific recognition of microbiomes and 
foreign molecules in the host. Innate immunity rapidly recognizes and reacts with the 
infectious agent, and therefore serves as the frontier of the immune system. Another 
essential function of innate immunity is to present antigens to the adaptive immune 
system[1]. Adaptive immunity the capacity to recognize the small regions of an antigen 
with specificity. These small regions are known as epitopes.  
The adaptive arm of the immune system adapts to the different antigen epitopes with the 
proliferation of clones of lymphocytes that distinctly recognize individual epitopes of the 
antigen. The antigen-specific clones of lymphocytes are known as“clonotypes” and 
produce antibodies and T effector cells that have different functions in combating 
infectious disease. Humoral immunity is the arm of the immune system that produces 
antibodies and involves T cells and B cells. “Cellular Immunity” is the arm of the 
immune system where antigen-specific T cells attack infectious agents and infected cells. 
The two arms of the adaptive immune system are composed of the lymphocytes subsets, 
T cells and B cells. 
1.1.2 T cell immunity 
1.1.2.2 T cell development in the thymus 
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Hematopoietic stem cells (HSC) in bone marrow (BM) are the precursors of myeloid and 
lymphoid lineages[2-5]. T lineage progenitors (ETPs)emigrate from the bone marrow and 
migrate to the thymus for further differentiation[6-9]. 
The T cell progenitors in the thymus cortex region lack expression of cell surface CD4 
and CD8, as well as the T cell receptor(TCR), and are defined as the double-
negative(DN) thymocytes. DN T cells undergo four stages of maturation, DN1-DN4 
maturational stages. During the DN2-DN4 phase, thymocytes express pre-TCR without 
rearrangement[10]. The initial expression of pre-TCR promotes ND4 thymocyte 
proliferation and expression of CD4 as well as CD8.Double 
positive(CD4+CD8+cellspre-TCR,)thymocytes further rearrange TCR differentiate into 
TCR double positive cells[11, 12]. DP thymocytes migrate into the medulla region and 
interact with epithelial cells. Cortical epithelial cells highly express MHC class, I or class 
II molecules loaded with self-antigen. The committed CD8 +DP thymocytes show a 
proper affinity with MHC class I[13], TCR signaling further enhance the CD8 expression 
of the CD8 +DP thymocytes. Committed CD4 +DP thymocytes with in optimal affinity 
for MHC class II, interact with class II expressing epithelial cells and TCR signaling 
enhancesCD4 expression.  Neither high affinity nor low-affinity of TCR-MHC Class 
interactions CD4+ or high affinity or low-affinity TCR-MHC class I interactions 
onCD8+wouldbe selected for in T cell-epithelial interactions. This process of CD4/CD8 
and TCR selection is termed as the positive selection.  
Before T cells can mature and emigrate to the peripheral lymphoid sites, committed 
thymocytes must interact with dendritic cells(DC) expressing high levels of MHC class I 
or class II molecules loaded with self-antigen. If the TCR on CD4+ or CD8+ T cells has a 
 13  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
high affinity for MHC-self antigen complexes, stimulated signaling will lead to cell 
apoptosis. Naive T cells with functional TCR and single CD8 or CD4 expression will not 
react with self-antigen and will migrate to the peripheral lymphoid sites. 
 
Figure 1.1. T cell development in the thymus[14]T cell development in the thymus 
Figure 1.1. T cell development in the thymus[14]T cell development in the thymus 
The thymus-settling progenitors (TSP) migrate into the thymus from bone marrow (BM). 
As these progenitors differentiate through the CD4–CD8– double-negative (DN)stages 
they lack expression of TCR and they migrate from the cortico-medullary junction to the 
cortex. The process of thymocyte differentiation can be further subdivided into DN1-DN4 
four stages. TCR β-chain rearrangement in the DN2-DN3 stage combines with the non-
rearranging pre-Tα chain. TCR α chain is not rearranged until the DP stage and 
generate complete αβ TCR. Interaction with cortical epithelial cells expressing MHC 
class I and class II, theαβ-TCR+CD4+CD8+ DP thymocytes further differentiate into 
CD8+ T cells,orCD4+ T cells based on the signaling that is mediated by the interaction 
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Figure 1.2. The T-cell receptor interacts with a peptide–MHC complex 
Figure 1.2. The T-cell receptor interacts with a peptide–MHC complex 
A functional αβT-cell receptor consisting of α- and β-subunit chains. Each subunit chain, 
the TCRβchain for example, consists of the variable (V), joining (J), diversity (D),and 
constant (C) region segments. The CDR3 region is the joint region of V,D, and J 
segments, which is crucial for antigen recognition. The TCR is present on the T-cell 
surface, binding with the antigen present with MHC molecule on the surface of an APC.  
The antigen-specific nature of T lymphocytes is based on the surface expression of the T 
Cell Receptor (TCR). Expressed as a heterodimer, the TCR plays a crucial role in 
antigen-specific recognition. TCR is a cell surface heterodimer consisting of αβ chains or 
δγ chains [15, 16].The αβ T cell is the most common, consisting of about 90%-95%of the 
T cells in the total T cell population. Highly homologous with the Immunoglobulin (Ig)-
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superfamily, TCR molecules have a variable region and conserved regions. The X-ray 
crystal structure of the αβ TCR-antigen-pMHC complex was first described in1996[17]. 
Hypervariable regions located in the variable region of the TCR have been found to bind 
to and recognize the antigen presented in the context of the major histocompatibility 
complex (MHC). This region is known as the complementarity-determining 
region(CDR)[18-21].Complementarity determining regions(CDR) include regions CDR1, 
CDR2, and CDR3. CDR1 and CDR2 are encoded by the V segment gene from the 
genome, whereas the CDR3 is combination of the V segment gene, D gene segment, and 
J gene segment. The CDR3 loop with high diversity undertakes the role for the antigen-
specific recognition[22].  
The investigation into the physical nature of CD3-antigen-MHC interactions 
demonstrated a two-step process of TCR MHC interactions. Initially, measurement of the 
affinity shows a low-affinity interaction of the complex, which may act as low sensitivity 
of the detector[23]. With dynamic observations of TCR-polymorphic MHC-antigen 
interactions using a BIAcore TM (Pharmacia Biosensor), Wu et al. [24] found two phases 
of binding and recognition. Initially, the TCR engages the MHC independent of a 
different antigen peptide. Later on, the TCR contacts the antigen peptide, and the MHC-
antigen-TCR complex then facilitates intracellular signaling resulting in antigen-specific 
T cell activation. 
1.1.2.3T cell receptor recombination 
1.1.2.3.1 T cell receptor 
As a member of the Ig-superfamily, the germline gene of the TCR gene is formed 
as a gene cluster into groups with different gene segments[25]. The human TRA(T cell 
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Receptor Alpha)gene and the TRD(T cell Receptor delta) gene are located on 
chromosome 14and comprise theTCRα/δlocus[26, 27]. TRA gene is organized in 
tandem-aligned pattern as Vα-Jα-Cα. The TRD gene is rearranged the same rule of TRA 
gene.  The TRB(T cell Receptor Beta)locus located on chromosome 7 
inhuman(7q34)encodes TCR βand is distinguished from the TRG(T cell Receptor 
Gamma) which is also located on chromosome 7[28]. 
 
 
Table 1.1. TCR gene location and classification 





TRA 14q11.2 54 -61 61 1 
TRB 7q34 64 2 14 2 
TRG 7p14 8 0 2 2 
TRD 14q11.2 3 3 3 1 
The TRA tandem-alignment pattern is arranged as Vα-Jα-Cα.TRB insert the D gene in 
the tandem-aligned pattern arranged asVβ-Dβ-Jβ-Cβ. Generally, TCR gene segments are 
flanked by short complementary palindromic sequences called recombination signal 
sequences (RSS). These signals are crucial elements for the somatic recombination of the 
TCR segments [29-31].Recombination signal sequences (RSS)are highly conserved 
7mer(heptamer),typically CACTGTG, and 9mer(nonamer), typically GGTTTTTGT, 
joined by a 12/23 constant sequence length. TCRB, for instance, each has a V gene 3' 
flanking RSS(7mer-23- 9 mer), with each J gene 5' region starting with RSS(9mer-12- 
7mer), and the D gene arrangement has the RSS on both sides[29-31]. 
1.1.2.3.2.V(D)J recombination 
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Figure 1.3. T cell receptor recombination 
αβ functional TCRs are heterodimers consisting ofα- and β-subunit chains that are 
generated by germline DNA recombination of variable (V), diversity (D) and junctional 
(J) gene segments for the β-chain. In the human TCR loci, there are 64 Vβ, 2 Dβ, 14 Jβ, 
54 Vα,and61 Jα functional gene segments. During T-cell differentiation, gene segments 
go through rearrangement and are further spliced with the constant region (C) to 
construct theαβ TCR,with each cell expressing a unique clonotype type of the recombined 
receptor. 
In T cell development, as previously described, T cells express pre-TCR without 
rearrangement until the double positive(CD4+&CD8+) stage. Thymocytes at the double 
positive stage first begin recombination by rearrangement between the Dβ gene and Jβ 
gene[32-35]. The recombination is dependent on the 12-23 rule[36-38]: First,the 
RAG1(recombination activating gene-1) and RAG2 (recombination activating gene -2) 
protein complexes recognise the two RSSs (generally one RSS(7mer-23- 9 mer) and one 
RSS(9mer-12-7mer) of the Dβ gene and the Jβgene and bring these gene segments into 
close proximity to form a stable synaptic complex. The RAG complex mediates the 
pairing of double-strand DNA cleavage in the synaptic complex. Next the dissociated 
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blunt-end DNA are repaired by the PolX family proteins (TdT, pol μ, pol λ),and DNA-
PKcs(DNA-dependent protein kinase catalytic subunit)and other proteins[39].There 
combined DJ gene continues to rearrange with the V segment gene with similar rules[40]. 
 
1.1.2.1. T cell subsets and functions and their association with the autoimmunity 
T cell has been characterized into several subsets according to their different functions, 
surface phenotypes, transcription factors, and cytokine-secreting.The classification of the 
T cell subsets is still unfixed and plastic and can interconvert from one subset phenotype 
to another subset. Figure(1.4.)shows the most typical T cell subsets, including CD4+ 
original T helper cells and CD8+ T cells. 
T helper type 1 (Th1) cells play an important role in adaptive immunity against 
intracellular viral and bacterial pathogens[41]. Th1 mainly produce IFN-γ; however, 
whether it plays a pathogenic or protective role in autoimmune disease remains 
controversial. It was first reported thatIFN-γ therapy for MS patients results in disease 
exacerbation[42].Subsequent studies, including human as well as animal models, further 
confirmed that the Th1 cells producing IFN-γare pathogenic[43-45]. This conclusion has 
also been challenged by some studies[46].T helper type 2 (Th2) cells are crucial for host 
defense against parasites and large extracellular pathogens and would induce allergic 
responses. For autoimmune disease,it has been found that Th2 plays a pathogenetic role 
which may be associated with B cell activation[47]. 
T helper type 17 (Th17) cells have been reported to be associated with autoimmune 
disease[48] and mucosal immunity[49, 50]. Th17 lineage is plastic would also be 
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interconverted into regulatory T (Treg) cells under TGF-βregulation[51].Th17 cells have 
been found to produce  IL-17 in both mice and humans[49].Regulatory T (Treg) cells 
have been found to play an important role as immunoregulators in many autoimmune 
diseases such as MS[52], asthma[53],and type 1 diabetes [54]. 
 
Figure 1.4. T cell subsets and their signature cytokine production 
Different CD4+ subsets were generated from naive CD4+ T cells include Th1, Th2, 
Th17, Treg1,Tfh. 
Apart from MHC-restricted T cells, some unconventionalαβT cells,which are not 
MHC-restricted T cells (figure 1.5), have also been identified [55]. The type most related 
to this study is the mucosal-associated invariant T 
lymphocyte (MAIT lymphocytes),which is an innate-like T cell with an invariant TCR α 
chain, highly conserved recombination with TCRA1-2 and TCRJ33 in humans [56]. 
MAIT has an antibiotic function would be activated by some bacterial metabolites 
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presented by the major classes of MHC Class I (MHC I)-Related Protein 1 (MR1). Pro-
inflammation cytokines have also been reported as activators of the MAIT lymphocytes. 
MAIT has been proved to be associated with autoimmune disease[57-60]; 
however, its association with multiple sclerosis remains controversial. MAIT-like T cells 
with the clonotype of Va7.2‐Ja33 T cells were first be found accumulated in a lesion of 
MS patients [61]. It is essential to determine the role MAIT plays in the MS patient, 
whether it is just stand-by a role in the MS lesion or whether it protects the CNS from 
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Figure 1.5. Overview of the unconventional αβ T cell family 
Interactions of unconventional αβ T cells with their antigen targets via their TCRs in 
human cells 
1.1.2.2.Cross-reactivity and autoimmunity 
Natural selection theory postulated by Niels K. Jerne in1955put forward a hypothesis that 
various antibodies to antigens naturally exist [62]. Later on, Burnet further adapted the 
natural selection theory and proposed the clonal selection theory which is widely 
accepted as" One cell -one-clonotype–one-specificity"[63]. After the work of several 
generations of immunologists, the basic form of the adaptive immune the TCR-MHC 
complex is the key to specificity of recognition-self antigens as well as recognition of 
neoantigens and thereby protect the body from disease and autoimmunity. However, 
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pathogenic immune responses derived from the improper interaction of TCR-MHC, 
which mistakes self-antigens as pathogenic antigens, causes autoimmune 
disease.Theoretically, autoreactivity T cells should have been eliminated by clonal 
deletion or inactivation during the negative selection and positive selection during T cell 
development. 
However, the above concept has been challenged by Don Masonwhoproposed that a high 
level of cross-reactivity and recognition of T cells and antigen is necessary for adaptive 
immune development and function [64]. Don Masonpredictsthe adaptive immune system 
needs 10^15 T cells to cover the different antigens, and this total amount of T cells is 
about 500kg in weight, which far exceeds normal human weight. It is impossible. So the 
natural selection theory needs further investigation to determine which cross-reactive 
combinations of TCR are actually in the adaptive immune system.T-cell cross-reactivity 
is defined as the ability of a given T-cell to be activated by two or more heterologous 
pMHCs. It has been found that memory HIV specific T cells were detected in the 
unexposed healthy population by Davis MM et al.[65]. Moreover, those HIV specific T 
cells exhibit cross-reactivity to other antigens. 
 
1.1.3 Immune Repertoire Research the Past and Present and the Future 
Originally, Southern blot and northern blot analysis were applied to immune repertoire 
research for the detection of TCR and PCR gene rearrangement patterns[66].CDR3 
spectratyping, originally called Immunoscope, was carried out to renew the analysis of 
the CDR3 length distribution[67, 68]. It was found that normal CDR3 length followed 
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Gaussian-like distribution[69-71]. This distribution was found to be perturbed in 
unhealthy conditions including infectious disease, cancer, and autoimmunity[67, 69, 71-
74].Multiplex genomic PCR combined with Sanger sequencing enriched the 
spectratyping analysis but was still unable to fully resolve the diversity of immune 
repertoire[75, 76]. Most studies on antigen-specific recognition of the immune cell 
receptor have been conducted at the protein level, such as immunoassays including 
ELISA and western blot to detect the specific antibody. Antigen-specific tetramers and 
the Vβ/Vα antibody combined with flow cytometry single-cell analysis has detected some 
antigen-specific CDR3s[77, 78]. Additionally, FACS and PANAMA-blot technology or 
antigen micro-array chips have also been applied in the identification of specific antigens 
for repertoire investigation[79]. 
The technical bottleneck of the immune repertoire studies is the vast diversity of the V 
gene and their massive recombination possibilities. With the development of next-
generation sequencing(NGS) techniques, it is now possible to amplify nearly all TCR or 
BCRof an immune repertoire and obtain sequence data and analysis from millions of 
individual TCRs[79, 80]. Consequently, the tremendous amount of immune repertoire 
data requires sophisticated and automated bioinformatics analysis. Apart from the basic 
analysis of the immune repertoire, CDR3'antigen-specific mapping still requires 
additional analysis. VDJdb, are recently developed a database of TCR sequences with 
known antigen specificity[81], makes it possible to analyze TCR antigen specificity 
among the TCR repertoire. However, the annotated TCR is only the tip of the iceberg, as 
most of the TCR remains unknown. Determining the network of the TCR repertoire 
would be a solution to predict the function the unknown TCR. The immune repertoire 
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applied to the different disease models, including cancer and autoimmune diseases as 
well as vaccination studies, may provide new insight into the adaptive immune response 
in different conditions. For instance, a functional association of the different clonotypes 
of T cells associated with antigen-specific T cell clonotypes may help define the 
pathogenic mechanisms of autoimmune diseases. 
1.2 Multiple sclerosis 
1.2.1 Autoimmune Disease overview 
Generally, autoimmune disease can be classified into organ-specific autoimmune disease 
and systemic autoimmune disease, based on the disease symptoms and pathology. Only 
one or a limited number of tissues and organs are affected in organ-specific autoimmune 
diseases, which may be caused by autoreactive T cells or antibodies to the tissue-specific 
antigens of the affected corresponding organ. The etiology of Hashimoto’s Thyroiditis, 
for instance, appears to be related to auto-antibodies and auto-reactive cytotoxic T 
lymphocytes(CTLs) against thyroid-specific proteins [82]. Systemic autoimmune disease, 
on the other hand, involves multiple organs or tissues injured through autoimmune 
mechanisms. The clinical presentation is more diversified and complicated than tissue-
specific autoimmunity. Systemic Lupus Erythrocytosis (SLE) involves autoimmune 
antibodies targeting same molecules, including single-stranded DNA, and results in 
autoimmunity involving multiple organs including kidney, brain, and connective 
tissue[83, 84]. 
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Even though vast amounts of research has been conducted on autoimmune 
diseases and advances have been achieved, how the immunological mechanisms of 
autoimmune diseases contribute to disease progression is just beginning to be understood. 
1.2.1.1.  Molecular Mechanisms of Autoimmune Disease 
Molecular mimicry is referred to as the pathogenic antigen sharing the similar epitope 
with the auto-antigen, which then causes the immune system to mistakes the self as non-
self. Amino acid sequence homology comparison is the most common method used to 
analyze the pathogen antigen with the self-antigen. 
Infectious pathogen epitope-mimicking autoimmune diseases have been summarized in 
table1.2.Theoretically, the high-affinity TCR-pMHC of the self-antigens depleted during 
cell development, so when healthy, the T cell is tolerant of the autoimmune disease target 
antigen. Somewhat paradoxically, the first encounter with the mimicking antigen of the 
pathogen should also be tolerant to the mimicking antigen, unless another mechanism is 
cooperating with the antigen mimicry to trigger the adaptive response. 
 
1.2.1.1.1. Exposure to the Self-antigens in Immunologically Privilege Tissues 
Some organs and tissues such as the central nervous system(CNS), the eye, the 
testis, and the pregnant uterus have natural anatomical barriers which lack immuno 
surveillance. So self-antigen from these sites are not recognized. These protected areas 
are often referred to as immune privileged sites [85, 86]. At times trauma or inflammation 
or surgery of these barriers allow the release of isolated self-antigen from these sites to 
the immune system and trigger adaptive immune responses against these self-
antigens[87]. The immune privileged concept has been challenged in recent years. For 
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instance, it was reported that meningeal lymphatic vessels present in mouse brain 
demonstrate, for the first time, a functional lymphatic system in the central nervous 
system[88], which indicates that the CNS is not absolutely isolated from the immune 
system. 
    1.2.1.1.2. Auto-antigen Structure Alteration 
Self-antigens may undergo modification by biological or chemical factors there by 
modifying self-antigens to undergo modifications to eventually become auto-antigen and 
cause an autoimmune response and disease[89, 90]. It has been reported that chlorination 
could modify self-antigens to generate auto-antigens and cause autoimmune disease[91]. 
It has been found that inSjögren' syndrome autoantigen alteration may be implicated in 
autoimmune injury[92]. 
  1.2.1.1.3.  Molecular Mimicry 
Molecular mimicry is often referred to as antigens originating from an infectious 
pathogen sharing antigen epitopes with similar epitopes of a self-antigen. The immune 
system in reacting against the foreign infectious disease attacks the pathogenic antigens 
and mistakenly also reacts with the similar self-antigens. The self-antigens now become 
auto-antigens, and immune reactivity with the host organs and tissues results in 
autoimmune disease. Amino acid sequence homology comparison analysis is the most 
common method to determine if the infectious pathogenic antigen can elicit self-antigenic 
responses by the immune system [93, 94]. 
Some infectious pathogenic epitopes that mimic self-antigens and cause autoimmune 
disease are summarized in table1.2.Theoretically, the high-affinity TCR-pMHC 
presentation of the self-antigens depleted duringT cell development. Under normal health 
 27  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
conditions, T cells are tolerant to autoimmune target antigens that can cause disease. 
Molecular mimicry appears paradoxical; however, epitope spreading and low-affinity 
antigens may play a role in molecular mimicry and autoimmune disease. 
1.2.1.1.4.Major Histocompatibility complex (MHC) associated with Autoimmune disease 
Epidemiology studies have established that a strong link exists with specific major 
histocompatibility complexes (HLA or MHC)antigens and the likelihood to develop 
autoimmune disease. One HLA type DRB1*0402is found to have a pocket structure that 
carries a higher risk for autoimmune diseases such rheumatoid arthritis(RA)[95].Large 
cohort genome-wide association studies(GWAS)from 
differentgeographicregionsalsofoundthatdifferentautoimmunediseasesshowanHLA bias 
for specific autoimmune diseases [96]. 
1.2.1.1.5. Dysfunction of the Treg Cell. 
Regulatory T (Treg) cells mediate homeostatic peripheral tolerance by suppressing auto-
reactive T cells[97, 98]. 
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Table 1.2. Autoimmune Disease and possible associated infectious diseases







Type 1 diabetes Beta cell antigens        
Rheumatic heart disease Cardiac myosin     M protein [99, 100] 
Rheumatoid arthritis Connective tissue, IgG  Mycoplasma， EBV, MCV  [101-103]    [104] 
Rasmussen’s encephalitis CNS-Antiglutamate receptor (GLUR3)  Herpes Simplex Virus (HSV)   [105-107]  -  - 
Guillain-Barre syndrome Gangliosides and peripheral nerve  Zika Virus  [108] Campylobacter jeuni[109, 110] 
Multiple sclerosis CNS-MBP    Herpes Simplex Virus (HSV)      [111] 
Addison's disease Cytochrome P-450 antigens         
Hashimoto's thyroiditis Thyroid cell antigens (e.g., thyroglobulin)Hepatitis C Virus(HCV), HTLV-I  [112-114]  -  - 
Graves' disease  Thyroid-stimulating hormone receptor         
Autoimmune hepatitis  Hepatocyte antigens (cytochrome P450 2D6)Hepatitis C Virus  [115-117]  HCV  [118] 
Autoimmune hemolytic anemia Red blood cell membrane proteins  Hepatitis C Virus,EBV [119, 120] - - 




 [123, 124] 
Systemic Autoimmune Disease 
systemic lupus erythematosus DNA, nuclear protein, RBC and platelet membranes EBV  [125, 126]  -  - 
Sjogren’s syndrome Salivary gland, liver, kidney, thyroidEBV,HCV  [127, 128]  -  - 
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1.2.2. Multiple sclerosis (MS)overviews 
Multiple sclerosis (MS) is an autoimmune disease characterized by destruction of 
the myelin sheath and axon loss within the central nervous system[129-133].  
1.2.2.1 Epidemiology of multiple sclerosis 
More than 2.3 million people in the world population are suffering from MS 
according to the Atlas of Multiple Sclerosis 2013 report revealed by the Multiple 
Sclerosis International Federation (MSIF) and the World Health Organization (WHO) 
joint project[134].The global prevalence in 2013 was 33 per 100,000. The prevalence 
varies with the geographical region. Europe and North America have a high prevalence 
according to the Kurtzke classification[135] and show a correlation with latitude[136]. 
However, the high prevalence of MS in Sardinian does not fit the latitude gradient 
distribution[137-139]. In Asia, especially, the prevalence of MS is low, but the incidence 
is reported to be increasing in recent years (ref)[140, 141]. For gender distribution, 
females are more at risk to develop multiple sclerosis than males [134]. The average age 
of MS onset is 30 years[134]. 
1.2.2.2. Clinical Manifestations and Course of Multiple sclerosis. 
The clinical manifestations of MS are variable according to the location of the 
lesson suffering in the brain[142-144]. Generally, the clinical course is classified into 
four types including primary progressive (PP), secondary progressive (SP),relapsing-
remitting (RR), and progressive relapsing (PR)[142].Relapsing-remittingMS(RRMS), 
which is the most common form of MS, relapse after periods of months to years of 
relative remission with no new signs of disease activity. Secondary Progressive Multiple 
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Sclerosis(SPMS) usually initiates with the RRMS.SPMS may have no remission after a 
secondary attack and cause a high percentage of disability. Primary Progressive Multiple 
Sclerosis(PPMS) is characterized by accumulative nerve injury and by a lack of distinct 
MS attacks. Different from PPMS,Progressive relapsing Multiple Sclerosis(PPMS)is 
characterized by accumulative nerve injury with distinct MS attacks. 
 
 
Figure  1.6.  Clinical Course of Multiple Sclerosis [143] 
MS can be classified into four clinical types, including primary progressive (PP), 
secondary progressive (SP), relapsing-remitting (RR), and progressive relapsing (PR) 
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1.2.2.3.Etiology of Multiple sclerosis. 
The etiology of the MS is unknown, but genetic, infectious[145], 
environmental[146], and immunological factors may play roles in the possible causes and 
development of the disease[147-149]. 
1.2.2.3.1 The genetic variant associated with MS 
HLA class II, as a key role in effector CD4+ T cell activation and function, has 
been extensively studied in different geographical regions using genome-wide association 
studies(GWAS).  In Europe, HLA alleles includingDRB1*15: 01, DRB1*03:01 and 
DRB1*13:03are associated with MS[96](HLA alleles includingDRB1*15: 01, 
DRB1*03:01 and DRB1*13:03as the risk alleles with an average odds ratio (OR) more 
than 1). Interestingly, HLA-A*02:01shows a protective effect against the development 
ofMS.  
 
  1.2.2.3.2 Infectious Factors associated with Multiple sclerosis 
The possible association of the development of MS after the infectious disease has 
been reported. Associated infectious microorganisms, include Chlamydia 
pneumoniae[150-154],HHV-6[155-158],EBV[159-165],Retroviruses[166-168], 
Coronaviruses[169, 170], and JC virus[171-173]. Direct virus isolation from the CSF or 
brain of the patients affected by the above-named infectious agents rarely reported, and 
most of the evidence for an association has been provided by serological research[157, 
174, 175]. 
Molecular mimicry between the antigens expressed by microorganisms and self-
antigens is a hypothesis that has been discussed for years. Sequence homology conserved 
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TCR recognizing motifs shared between viral peptides and self-antigens, and structural 
mimicry is known as the“molecular mimicry theory” [176]. MBP (85–99)-specific TCR 
and EBV peptide mimics have been reported in many studies[5, 7, 177]. 
1.2.2.4.Pathology of Multiple Sclerosis 
  1.2.2.4.1.CNS structure in homeostasis 
The CNS is protected by the skull and the meninges anatomically. The meninges 
from inside out is comprised of pia mater, arachnoid mater, and vascularized dura 
mater[178].Cerebrospinal fluid(CSF) flows in the space between arachnid and pia mater 
and functions as a homeostatic factor for CNS function[178]. The blood-brain 
barrier(BBB) is another essential component that protects the CNS parenchyma from 
harmful substances such chemical compounds, peptides, and proteins, as well as 
microorganisms and some immune cells. It is widely accepted that the CNS is an 
immune-privileged organ, in part because of the BBB. During the homeostatic state, 
blood-borne immune cells circulate through the meningeal spaces and do not cross the 
blood-brain barrier (BBB). The microglia, considered to be CNS resident macrophages, 
take the responsibility of innate immune surveillance in the brain parenchyma[179]. 
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Figure  1.7. Myelin sheath on the healthy nerve of axon and Demyelination in MS. 
The normal nerve conduction by saltatory conduction the propagation of action 
potentials through myelinated axons from one node of Ranvier to the next.Saltatory 
conduction is a very efficient way for the nerve conduction which is highly base on the 
healthy anatomical structure of the axon which is covered by a myelin sheath. In the 
pathological feature of MS are inflammation, demyelination which cause the block of the 
nerve conduction. 
  1.2.2.4.2.Pathology of Multiple Sclerosis 
The pathological features of MS are inflammation, demyelination, and neuro-
degeneration focally or diffusely throughout the white and grey matter in the brain and 
spinal cord, leading to remyelination and glial scar formation in the chronic disease 
process. 
In the acute stage of MS lesions, the infiltration of lymphocytes along with the 
activation of microglial is found in perivascular and parenchymal areas[180]. 
In the classic MS lesion, demyelination plaques are the hallmark of all stages of 
MS patients. MOG-specific MBP-specific antibodies bound with myelin have been 
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detected in situ in the MS lesions, indicating the autoimmune response in MS pathology 
[181]. 
 
1.2.2.5.  The immunological mechanism of Multiple Sclerosis (MS) 
1.2.2.5.1.CD4+ T cells 
The adaptive immune system plays central role in the immunopathogenesis of 
multiple sclerosis[182].Oligo clonal IgG bands (OCBs) detected in cerebrospinal fluid is 
a hallmark of multiple sclerosis(MS)[183-186] and indicate that plasma cells are 
responsible in part for the pathogenesis of MS. It is believed that the OCBs are products 
of the antigen-specific B cell clonal expansion[186]. However, recent studies using NGS 
of the BCR repertoire and using mass spectrometry revealed that the OCBs are partially 
heterogeneous auto-reactive antibodies and have an overlapping repertoire with that of 
peripheral blood cells [187]. The status of the TCR repertoire of T helper cells (Th), an 
indispensable part of T cell-dependent immunoglobulin production, is critical to the 
understanding of the role of Th cells in MS pathology. Naive CD4+ T cells recognize 
antigen presented by MHC class II on the antigen present cell(APC) and differentiate into 
several subsets of Th cells with different functions and phenotypes [188-190]. The 
mature Th cell further differentiates into Th1, Th2, and Th17 T helper cell subsets. These 
subsets are the basis of cytokine production and the phenotype of each cell type[188].Th2 
cells are the major producers of IL-10 and may have a protective role in the development 
of autoimmune disease development[191, 192]. Th17 cells, the major producers of IL-17, 
recently have been demonstrated to be correlated with MS activation and relapse and are 
also highly correlated with other autoimmune diseases[193-195].  
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1.2.2.5.1.CD8+ T cells 
CD4+ T cells were originally considered the main T cell subset for the induction 
of immunopathogenesis of MS[196]. However, recently, GWAS and histopathological 
studies have implicated that CD8 +T cells are critical in the pathogenesis of multiple 
sclerosis[143, 197]. Histopathological studies show cells (CTL) infiltrate multiple 
sclerosis plaques in the relapsing, persisting and the chronic stages of disease indicating 
thatCD8+ T cells may be directly involved in the immunopathogenesis of myelin sheath 
destruction[198, 199].In the mouse animal model, experimental autoimmune 
encephalomyelitis (EAE)studies demonstrated that-MOG specific CD8 T cells [200] and 
MBP specific CD8-T cells[201] induce autoimmune responses in CNS. Neuroantigen-
specific T-cells have also been identified in the analysis of T cells in MS patients [72, 
202-208]. These studies suggest T cells play a role in the autoimmune pathogenesis in the 
disease process. However, CFLs are not recruited, and clonal expansion does not take 
place in the CNS until inflammation occurs as the BBB(blood–brain barrier) restricts 
immune cell entry[209]. Due to the limited number of immune repertoire libraries and 
sequence data, further investigations are needed to identify the possible pathogenic T cell 
clonotypes involved in the destruction of the myelin sheaths and axons. Myelin basic 
protein (MBP)[210-213] and myelin oligodendrocyte glycoprotein (MOG)[214-217]and 
proteolipid protein (PLP)[213, 218, 219]from neurons have been widely studied as the 
relevant self-antigens in MS. However, the relationship between these proteins and T cell 
receptors and the etiology of multiple sclerosis still unknown. 
It was long thought that the CNS lacked lymphatic vessels. However, the recent 
finding showing that meningeal lymphatic vessels are present in mouse brain 
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demonstrates for the first time a functional lymphatic system in the central nervous 
system[88]. Does it pose new questions for MS immunopathogenesis: Is the central 
nervous system under constant lymphocytic surveillance? If so, what are the regulatory 
mechanisms and regulatory cells? What happens during autoimmune disease to the 
regulatory mechanisms? 
First of all, where is the site of pathogenic expansion for T cells and B cells 
during the development of MS?  Does the peripheral blood and CSF share the 
clonotypes with the lesions of MS patients? 
Secondly, what are the baselines of the autoreactive T cells and antibodies in the 
healthy population and the healthy state of the MS patient before disease onset? 
Thirdly what is the initiating stimulant to the immune response causing the auto-
reactive process in the CNS? What is the pathogen's epitope sharing similarity with the 
self-antigen, if molecular mimicry is the universal mechanism of autoimmune disease? 
  The last but the most interesting mystery is how the immune cells coordinate 
with each other and the different clonotypes and cause autoimmunity.  
Sardinia is a high-risk area of MS(multiple sclerosis)[220-222]. The genetically 
homogeneous population resulting from geographical isolation may be a critical factor 
that contributes to the high prevalence of the MS in Sardinia. 
Using next-generation sequencing, the TCR repertoire can be sequenced 
providing a snapshot and a general view of autoreactive T cells as well as possible virus-
specific T cells and their role in the disease process. Here we sequenced the T cell 
repertoire of 13 cases of multiple sclerosis patients as well as 21 healthy volunteers. The 
TCR repertoires show differences between multiple sclerosis patients and healthy 
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controls. Multiple sclerosis patients have a higher repertoire of diversity than the healthy 
control patients.  
 
 
1.3Specific aims of this thesis 
I hypothesise that: 
 
• Multiple Sclerosis patients have a unique TCR repertoire distinguished from the 
healthy population.  
• Molecular mimicry and cross-reactivity of self-antigens and viral epitopes may be 
one the immunological mechanism of Multiple Sclerosis.  
 
To address this hypothesis, we set the following aims for this project: 
Analyze the TCRβ repertoire of multiple sclerosis patients and healthy controls. 
Analyze the TCR α repertoire of multiple sclerosis patients and healthy controls. 
Annotate the TCR repertoire and determine the possible association between the 







 38  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 












 39  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
 
Table 2.1 Reagents 
Reagents Source Catalog 
DMSO Sigma D2650 
RPMI-1640, sterile, L-glutamine and HEPES Thermo Fisher R7388 
GE Healthcare Ficoll-Paque™ PLUS Media Fisher Scientific 45-001-749 
TRIzol™ Reagent Thermo Fisher 15596018 
Chloroform Solution Sigma  613312-1EA 
Isopropanol  Sangon Biotech A507048 
RNase-free water Takara 9012 
Fetal bovine serum (FBS) Thermo Fisher 10099141 
Trypan blue, 0.4% solution Thermo Fisher T10282 
RNA zap Thermo Fisher AM9782 
AMPure XP beads Beckman NC9933872 
Qubit™ dsDNA HS Assay Kits Thermo Fisher MAN0002326 
SMARTer® Human TCR a/b Profiling Kit Clontech 635016 
 
Table 2.2. Accessory Products and Instrumentations 
Product Source 
BD Vacutainer™ CPT™ Tube with sodium heparin BD Biosciences, 
Disposable polystyrene serological pipette Discovery Labware 
Sterile polypropylene conical tube, 50 mL Crystalgen 
1.8 and/or 3.6 ml cryovial, Nunc or equivalenta Nunc 
Pipettes (0.5 – 10 µL,2 – 20 µL,10 – 100 µL,100 – 1,000 µL) eppendorf  
Biological safety cabinet Eppendorf  
Refrigerated centrifuge Eppendorf  
PCR Cyclers-Mastercycler® nexus eppendorf  
Agilent 2100 Bioanalyzer Agilent 
The Qubit Fluorometer Thermo Fisher 
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2.2.1. Peripheral blood mononuclear cells Isolation 
4 ml of peripheral blood was collected from each participant with an 
EDTA tube. Centrifuge1000rmp for 15min at 4°C to separate the plasma 
from blood. Dilute remaining blood at the ratio1:2 with PBS/physiological 
saline solution. For instance,15ml blood + 35ml physiological saline solution. 
Layer up to 10 ml of the diluted sample over 5 ml ficolin a 15 ml tube(ratio 
2:1).Centrifuge for 2200rmp for 30 minutes at 23°C. If blood is stored for 
more than 2 hours, increase centrifugation time to 30 min (as per gradient 
medium instructions).With the centrifuge brake off. Collect PMNC from the 
interface and transfer cells to a new 15 ml centrifuge tube. Wash PBMC with 
PBS by centrifugation at 1600rmp for 5 min at 23°C.Remove 
the  supernatant into a new 15 ml tube for a further centrifuge. Resuspend the 
remaining cells with 15 ml PBS. Centrifugation at 1800rmp for 8 min at 
23°C. Remove the supernatant and pull out all the cell into one tube and add 
PBS/physiological saline solution at final volume 4ml. Dilute the cell solution 
with PBS in a 5 ml round-bottom test tubes at the ratio 1:10(20ul PBMC+ 
180ul PBS/physiological saline solution)Counting the cell.Centrifuge the cell 
solution at 1800rmp for 8 min at 23°C. Resuspend the remaining cells to 2 x 
106 per ml in PBS 
 
2.2.2. RNA extraction 
⚫ Add 750 ul of TRIzol® Reagent for each sample.Incubate in room temperature 
for 5 minutes. Add 200ul chloroform and shake the tube vigorously for about 15 
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sec. (at a ratio of 1 part chloroform to 5 parts TRIzol). Centrifuge the sample at 
12,000 rpm for 15 minutes at 4°C. Place the aqueous phase into a new tube， 
Add 500ul of 100% isopropanol to the new tube  Incubate at room temperature 
for 10 minutes. Centrifuge the sample at 12,000 rpm for 10 minutes at 4°C. 
Remove the supernatant from the tube.Wash the pellet, with one mL of 75% 
ethanol per 1 mL of TRIzol® Reagent used in the initial homogenization. Vortex 
the sample, then centrifuge the sample at 12000 rpm for 5 minutes at 4°C. 
Discard the wash. Dry the RNA pellet for 10 minutes. Resuspend the RNA pellet 
in RNase-free water. Incubate at 55–60°C for 10–15 minutes. Proceed to 
downstream applications, or store at –70°C.RNA concentration and purity were 
measured with Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto, CA). 
 
 
2.2.3.TCR library construction  
SMARTer Human TCR a/b Profiling Kit was used for the TCR library construction. 
This kit is base on a 5’ RACE-like approach to amplify complete V(D)J variable regions 
of TCR transcripts.  
⚫ First-strand cDNA synthesis 
First-strand cDNA synthesis is performed by Moloney Murine Leukemia Virus Reverse 
Transcriptase (MMLV)-derived SMARTScribe™ Reverse Transcriptase (RT) and dT-
primed), which adds nucleotides upon reaching the 5’ end of each mRNA template[223]. 
Non templated nucleotides anneals the 5’ end of each mRNA template by the SMART-
Seq® v4 Oligonucleotide and serves as a template for the reverse transcription into the 
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first-strand cDNA. This additional sequence, non templated nucleotides, —referred to as 
the “SMART sequence.”The artificial knowing SMART sequence would serve as a 
primer-annealing site for subsequent rounds of PCR, ensuring TCR region from full-
length cDNAs undergo amplification. The anneals SMART sequence overcome the 
bottleneck of the high diversity of TCR V segment gene. 
⚫ The First PCR Amplification 
After reverse transcription-PCR, the first-strand cDNA as a template further amplify by 
SMART Primer 1 and reverse primer that is 
 complementary to the constant region. Both reverse primers may be included in a single 
reaction if analysis of both TCR subunit chains is desired. By priming from the SMART 
sequence and the constant(C)region, the first PCR specifically amplifies the entire V 
region and a considerable portion of the constant region of TCRα and TCR-β cDNA. 
⚫ The second PCR amplification 
With the product of the first round PCR as a template, further, perform semi-nested PCR. 
The reverse primer is a portion of the constant region of TCR-α and TCR-β cDNA. Both 
forward primer and reverse primer contain the nucleotides of p5 and p7 which is the 
primer for Illumina sequencing. Following post-PCR purification, size selection, and 
quality assay, the library is ready for sequencing. 
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Figure 2.1. Workflow for SMARTer Human TCRa/b Profiling 
 
2.2.4.The Quality Control of The NGS Library of TCR Immune Repertoire 
 
Before the library sequencing on Illumina platforms. The library validation is necessary 
to have an idea of the library quality. The thefollow item should be taken into 
consideration. 
①Mass Concentration Quantification：■Agilent 2100; ■Qubit quantitation assay; ■
Nanodrop 
②Library FragmentValidation：■Agilent 2100 
③Molar Concentration Quantification：■Q-PCR  
Library Validation: 
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①Concentration Quantificationmeet the request concentration >1nM at least 50 ul on 
Miseq platform for BGI. 
②TCR-α or TCR-β sequence fragments yield electropherogram maxima that tend 
toward the upper and lower ends of the 700–800 bp size spectrum. 
 
Figure 2.2. Example electropherogram results of the TCR repertoire library. 
TCR-α or TCR-β sequence fragments yield electropherogram maxima that tend toward the upper 
and lower ends of the 700–800 bp size spectrum. 
The final TCR library was shipped to NGS company BGI China (BGI diagnostic 
Laboratories, Shenzhen, China) perform. The library was sequencing on the 
IIlluminaMiSeq® sequencer using the 600-cycle MiSeq Reagent Kit v3 (Illumina, Cat. 
No. MS-102-3003) with paired-end, 2 x 300 base pair reads. 
2.2.5.Next-generation sequencing data analysis 
A first initial quality control assay was used FastQC. Adapter and quality 
trimming as well as pairing Fastq-join were performed by ea-utils. The joined fastq rerun 
the fastQC for the quality control. TCR alignment and αTCR/ βTCR clonotypes exported 
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by MIXCR for downstream analysis. VDJtoolswas applied for the analysis the data post-
MIXCR for comparative post-analysis of TCR repertoires include basic statistical 
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Results 
To investigate the T Cell Receptor β Repertoire of individuals diagnosed with Multiple 
Sclerosis (MS), we sequenced the T Cell Receptor β(TCRβ) repertoire from peripheral 
blood obtained from MS patients and control individuals of Sardinian origin. The 
objective of this portion of the study was to identify the possible clonotypes associated 
with Multiple Sclerosis disease. Furthermore, if functional clonotypes were revealed we 
wanted to determine if any clonotypes were associated with recognition of antigens of 
infectious disease origin. 
2.1. Basic analysis of TCR-β repertoires  
TCR-β repertoires were sequenced and analysis performed from individuals with 
multiple sclerosis and healthy volunteers. We were able to obtain functional TCR-β 
CDR3 with an average of 95%  (CI11507± 3612 N=13)  for the MS group and an 
average of 95%  (CI  19604 ± 3534 N=21) for the control group. To exclude cross-
sample contamination, the data was processed with a decontamination filter. Differences 
in TCRBV CDR3 length (Fig. 3.1A)  (P= 0.3837) was not observed between the MS 
patients (43.62 ± 0.06532 N=13) and healthy controls(43.38 ± 0.2095 N=21).Mean some 
nucleotides that lie between V and J segment sequences in CDR3 (Fig. 3.1B) was not 
significantly different between multiple sclerosis (12.65 ± 0.07071 N=13) and healthy 
volunteers (12.52 ± 0.2158 N=21). Mean some inserted random nucleotides in CDR3 
sequence(Fig. 3.1C) was not significantly different between multiple sclerosis (4.731 ± 
0.03622 N=13) and healthy volunteers (4.713 ± 0.1411 N=21). Convergence of mean 
number of unique CDR3 nucleotide sequences(Fig.3. 1D) that code for the same CDR3 
 48  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
amino acid is also similar(P=0.2645) between multiple sclerosis (1.007 ± 0.001305 
N=13) and healthy controls (1.008 ± 0.001069 N=21). 
Table 3.1. Basic information of Multiple Sclerosis patients. 
. 
































M 44  10  NO 
C4*  HLA-DRB1*0405-
DQB1*0301   HLA-
DRB1*0405-DQB1*0302 
F 43  9  NO 
C8 HLA-DRB1*0405-
DQB1*0301   HLA-
DRB1*0405-DQB1*0301 
F 47  22  NO 
C9 HLA-DRB1*0405-
DQB1*0301   HLA-
DRB1*0405-DQB1*0302 
F 62  12  NO 
C10 HLA-DRB1*0405-
DQB1*0301   HLA-
DRB1*0405-DQB1*0302 
M 66  50  2016/4/1 
C11 HLA-DRB1*0405-
DQB1*0301   HLA-
DRB1*0405-DQB1*0301 
F 42  10  2015/11/1 
C13*  HLA-DRB1*0405-
DQB1*0301   HLA-
DRB1*0405-DQB1*0302 
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Figure3. 1.  A. Mean length of CDR3 nucleotide sequence weighted by clonotype 
frequency. C. Mean number of inserted random nucleotides in the CDR3 sequence. B. 
Characterizes V-J insert for receptor chains without D segment, or a sum of V-D and D-J 
insert. D convergence means a number of unique CDR3 nucleotide sequences that code 
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2.2. Diversity estimation of TCR-β repertoires  
We next compared the diversity by different indexes. Lower bound total diversity 
estimates (LBTE) include chao1(Fig 3. 2A) (p=0.5952) efron Thisted (Fig 3.2B) 
(p=0.5044) analysis which showed no difference between the MS patients with the 
healthy controls. The Shannon Weiner Index(Fig. 3.2C) (p=0.3700) and chaoE(Fig.3.2F) 
(p=0.3124) also agree with the LBTE results. However, whether diversity indices were 
used we obtained a different result: the normalized Shannon Weiner 
Index(Fig.3.2D)(p=0.0074)and Inverse Simpson index (Fig. 3.2E) showed multiple 
sclerosis patients have higher diversity than healthy controls.  All sample were re-
sampled and normalized to exclude a sampling depth effect.  As chaoE is recommended 
to compared between samples, so we could generally consider MS, and the healthy 
controls are similar in total diversity estimation, but MS patient repertoires have higher 
entropy when compared with healthy controls. The amount of a difference in the 
clonotypes, which may contribute to the entropy of the repertoire diversity, between the 
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Figure 3.2. Comparison of TCRβ repertoire diversity index between MS and 
controls. (A) Chao estimate (denoted chao1) (B) Efron-Thisted estimate (C) Shannon-
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2.3.Clustering and overlap of TCR-β repertoires 
 
We next used cluster analysis to investigate the overlap of the CDR3 
amino acid sequences in each sample. After Hierarchical clustering analysis, the 
dendrogram (Fig.3.3A) shows that the MS group forms a distinct cluster. MDS (Multi-
dimensional scaling) (Fig.3B) also verified that MS patients form a cluster distinguished 
from the healthy controls. Permutation testing (Fig.3.3C) based on MDS of the CDR3 
shows that the TCR-β repertoires of the MS group show a significant difference from the 
healthy controls. We did not find an obvious diffusion in the MS group of functional 
CDR3 as has been recently reported[224].  However, in our study, we found a 
difference in the MS group of all clonotypes including the out-frame and in-frame 
clonotypes. 
From this, we conclude that MS patients have a different TCR-β repertoire when 
compared with healthy controls. Our next step was to determine what are the unique 
clonotypes of the MS patients. Furthermore, are these clonotypes responsible for the 
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Figure 3.3. A. Hierarchical clustering 
of a healthy donor and multiple 
sclerosis (MS) patient samples. B. 
Multi-dimensional scaling (MDS) plot 
of all sample, Controls(Green), Multiple 
Sclerosis(Red). C. Permutation testing 
between the Multiple Sclerosis(MS) 
with Controls of the distance based on 
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4.4. The Variable (V) and Joining (J) segment usage  
 
Previous work has been performed on the TRBV gene usage bias in MS patients  
[224, 225].V/J gene usage profile analysis by hierarchical clustering based on Euclidean 
distance was also performed on our data to determine TCRβ segment usage in our MS 
patients and healthy controls. The heatmap of the V/J gene segment usage (Fig.3.4) did 
not show any obvious clustering differences between MS patients and the healthy 
controls.  For the V gene segment, a cluster of the (C3,C6,C2,C1,C9,C4), and J gene 
(C4,C1,C2,C13,C10) was observed (Fig.3.4). We next examined each gene usage and 
determined and performed statistical analysis. TRBV23.1 and TRBV3.1 have a higher 
statistically significant frequency in healthy controls. Table 3.2 shows the list of the 
important V gene usage in the MS patients and healthy controls. The previously reported 
MS associated variable genes including TRBV5-6 (P =0.98) and TRBV5-1 (P=0.4811) 
[224]has the same level frequency in MS group and healthy controls in our study. The 
TRBV20-1(p-value=0.0792) previously reported has a higher frequency in multiple 
sclerosis groups. This gene has also been reported in the Sardinian population, but the 
null allele did not influence the risk of multiple sclerosis, however, more data sets are 
needed to determine if statistical differences can be achieved. For the TRBJ gene 
usage,TRBJ1.5(p-value=0.004061) and TRBJ1.4 (p-value=0.03988) have a higher 
frequency of usage in the MS group. 
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Although the TRBV20-1 gene usage was not significantly different between the 
MS and the healthy controls, we did, however, find that the Variable-Joining segment 
rearrangement TRBV20.1$TRBJ2.1(p=0.01223) and TRBV20.1$TRBJ1.5(p=0.04875) 
(Table.3.4) show a significant increase the MS group. Interestingly, this rearrangement 
pattern frequency is more than 1%. 
 
 
Figure3. 4. Hierarchical clustering of samples based on the Euclidean distance 
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Table 3.2. V gene usage in MS patients and Healthy controls 
V gene Controls MS p-value 
TRBV23.1  0.000333 0.000101 0.03571 
TRBV21.1  0.002154 0.003022 0.05548 
TRBV6.4 0.006353 0.003473 0.05544 
TRBV5.6  0.019996 0.019841 0.98 
TRBV3.1  0.026739 0.016178 0.002162 
TRBV5.1 0.098168 0.10764 0.4811 
TRBV20.1  0.104435 0.123383 0.0792 
 
Table2. 3. J gene usage in MS patients and Healthy controls 
J gene Controls MS p-value 
TRBJ1.4  0.027317 0.043298 0.03988 
TRBJ1.5   0.055716 0.06732 0.004061 
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Table 2.4. V-J junction of MS patients and Healthy controls 
V-J junction Controls MS p-value  
TRBV19$TRBJ1.3  5.3151E-05 0.00026 0.03939 
TRBV21.1$TRBJ2.5 0.00011923 0.00048 0.03879 
TRBV5.6$TRBJ1.5 0.00087559 0.00295 0.04661 
TRBV5.5$TRBJ1.4  
0.0003248913           
0.0008485224  
0.00085 0.01746 
TRBV12.4$TRBJ2.4 0.00024834 0.00061 0.0412 
TRBV4.3$TRBJ1.3 0.00041331 0.00096 0.00727 
TRBV5.4$TRBJ2.1 0.00034233 0.00072 0.02828 
TRBV5.6$TRBJ2.3  0.00102444 0.00211 0.00232 
TRBV12.4$TRBJ2.3 0.00154772 0.0029 0.00326 
TRBV7.6$TRBJ2.3  0.00139905 0.00253 0.01444 
TRBV15$TRBJ1.2 0.00086822 0.00152 0.03137 
TRBV4.1$TRBJ1.1 0.00169047 0.00287 0.03532 
TRBV12.4$TRBJ1.1  0.00233696 0.00394 0.03131 
TRBV4.3$TRBJ1.1 0.00166354 0.00274 0.0108 
 TRBV19$TRBJ2.7 0.00061349 0.00099 0.0323 
TRBV12.4$TRBJ2.2 0.00158877 0.00257 0.02417 
TRBV5.6$TRBJ2.1 0.00199412 0.00322 0.00034 
TRBV6.6$TRBJ2.5  0.0004826 0.00077 0.01659 
TRBV2$TRBJ2.7  0.0025739 0.00377 0.01242 
TRBV20.1$TRBJ2.1 0.01718289 0.02225 0.01223 
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Figure 3.4. Significant usage of V&J gene between MS patients and the healthy 
controls. A. J gene segment usage of TCR β chain. B. V segment gene usage of TCR β 

































































































































































































































































 59  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
3.5 MS associated CDR3 of TCR-β repertoires  
 
We merged all the clonotypes of the MS patients and the healthy controls and 
determined the frequency of each unique clonotype using the Wilcoxon test.  119 unique 
TCRB CDR3(P<0.05) were obtained that have a higher frequency in MS patients. To 
determine the function of that MS-associated CDR3, the high-frequency CDR3 
clonotypes were annotated by using the database VDJdb[81].  One of the clonotypes 
with the predicted amino acid sequence, CASSFGQGNTEAFF, and having a p-value of 
(p=0.0255), is a BMLF1 specific CDR3 clonotype [226]. BMLF1 is an antigenic peptide 
found in the Epstein Bar Virus. 
The MS associated CDR3 repertoire V-J recombination results also validate the 
previous V-J usage results above. TRBV20.1$TRBJ2.1 is the highest percentage V-J 
recombination in the MS associated CDR3 repertoire at 5% of all V-J recombinations. 
TRBV20.1$TRBJ2.1 at 2% is the dominant recombination in the MS group individually. 
However, in the control group, the V-J recombination with the highest percentage is 
TRBV7-2$ TRBJ2.7 at 2.6%. Spectratype profiling of the MS-associated CDR3 did not 
show obvious skewing comparing the total MS patients TCRB repertoire as well as the 
controls. However, the single V gene shows a bias feature; it is likely to be caused by the 
limited MS associated CDR3 clonotypes.   
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Chapter III Summary 
In this chapter, I have highlighted that MS patients present a different TCR-β 
repertoire compared to the healthy populations in our Sardinia cohort. Dendrogram and 
Multi-dimensional scaling (MDS) plot base on the TCR-β repertoire shows that the MS 
patients split into a cluster distinguish with the healthy populations. Permutation testing 
based on MDS of the CDR3 further confirmed that the TCR-β repertoires of MS group 
show a difference with the healthy controls. Alterations in length of CDR3 of TCR-β 
repertoire was not observed in our MS patient cohort. According to our most recent 
analyses, diversity skew in MS patients TCR-β repertoire is not supported by our data. 
 To further identify what unique clonotypes MS patients have, we firstly analysis 
the frequent high variable (V) and joining (J) segment usage in MS patients compared 
with the healthy controls. We found TRBV23.1 and TRBV3.1 have a higher statistically 
significant frequency in healthy controls. For the TRBJ gene, usageTRBJ1.5 and 
TRBJ1.4 are more higher frequency usage in the MS group. We found that the Variable-
Joining segment rearrangement TRBV20.1$TRBJ2.1and TRBV20.1$TRBJ1.5show a 
significant increase MS group.TRBV20-1 gene is high frequent used in Sardinia 
population. Meantime we found TRBV20-1 has certain rearrange pattern with J gene has 
a higher level in the MS patients in Sardinia. Our result highlighted thatTRBV20-1 gene 
is a critical variable (V) gene segment need further investigation.  
Then we have identified 119 unique MS associated CDR3 of TCR-β 
clonotypes.BMLF1(EBV) specific CDR3(CASSFGQGNTEAFF) has been identified 
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among those MS associated CDR3 of TCR-β repertoire indicated that MS maybe have an 
association with the EBV infection. 
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Chapter IV. 
TCell Receptor αRepertoire of Sardinian Multiple Sclerosis Patients 
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To investigate the T Cell Receptor αRepertoire of individuals diagnosed with Multiple 
Sclerosis (MS), we sequenced the T Cell Receptor α(TCRA) repertoire from peripheral 
blood obtained from MS and control individuals of Sardinian origin. The objective of this 
portion of the study was to identify the possible clonotypes associated with Multiple 
Sclerosis disease. Furthermore, if functional clonotypes were revealed we wanted to 
determine if any clonotypes were associated with recognition of antigens of infectious 
disease origin. 
 
4.1 Basic profiling of the TCRαrepertoires in MS Patients and Controls 
The top 800 clonotypes were filtered from the decontamination TCR-α repertoires 
and analyzed to remove the PCR amplification bias.  CDR3 length alterations of TCRA 
in MS patients compared to healthy controls (HC) is shown in Fig. 4 1C(MS, 
42.73172±0.0315011 N=13 vs  HC, 41.40594±2.6200671 N=21). The mean number of 
inserted random nucleotides in CDR3 sequences is not significantly different (p=0.4222) 
between multiple sclerosis (4.830006±0.4820947 N=13)and healthy controls 
(4.51952±1.1030651 N=21). MS spectratyping plot show (Fig.4. 1C) 
CALSDQKYSGGGADGLTF rearranged by TRAV9-2&TRAJ45 is the top 3 clonotype 
among the repertoire of MS patients. 
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 The inserted nucleotides in the CDR3 region of TCR α chain does not appear to 
be the reason for the alteration of CDR3 length. If it were the biased usage of V/J gene 
would contribute to this difference. Convergence indicates the number of unique CDR3 
nucleotide sequences that code for the same CDR3 amino acid is similar (P=0.883) in 
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Figure 4.1.  CDR3 Length Distribution of TCRα Chain. The spectral type plot 
displays of CDR3 lengths and top 10 clonotypes in MS patients (A), Controls (B), (C) 
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4.2.Clustering and overlap of TCR-α repertoires  
Overlap analysis of  CDR3 amino acid sequence in the repertoire from 
individual samples was processed and used to construct a hierarchical clustering tree. 
After Hierarchical clustering analysis, the dendrogram clustering tree(Fig.4.3.A) shows 
that the MS group has one major cluster. MDS(Fig.4.3.B) also verified that MS patients 
have a cluster distinguished from the healthy controls. Permutation testing (Fig.4.3.C) 
based on MDS of the CDR3 shows that the TCR-α repertoires of MS group show a 
difference with the healthy controls.  
These results suggest that the MS patients have a different TCR-α repertoire when 
compared with healthy controls, and the results are consistent with our TCR βRepertoire 
results from Chapter III. Again, we ask if there are unique clonotypes of the MS patients 
that are specific for their pathology and disease. Mechanistically our question is where 
these clonotypes are responsible for the pathological autoreactive responses in MS 
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Figure 4.2. A. Hierarchical clustering of healthy donors and multiple sclerosis (MS) 
patients.B. Multi-dimensional scaling (MDS) plot of all ample, Controls(Green), Multiple 
Sclerosis(Red). C. Permutation testing between the Multiple Sclerosis(MS) and Controls 
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4.3. Variable (V) and Joining (J) segment usage in MS patients 
Hierarchical clustering of V/J gene usage profiles based on Euclidean distance 
was performed on our MS and control cohorts (Fig.4.3.). The heatmap of the V/J gene 
segment usage did not show any obvious clusters for either the MS group or the healthy 
control group (Figure 4.3.).  For V segment gene usage however,there is a cluster of 
theC7,C2,C1,C9,C4, and for J gene a cluster C4,C1,C2,C9. We further examined each 
gene usage and performed statistical analysis. TRAV 12.3, TRAV27, TRAV38-2DV8, 
TRAV5as well as TRAJ11, TRAJ15, TRAJ17, TRAJ52, and TRAJ6. Figure 4.4.Shows 
significantly higher frequency of these genes in MS patients. Table4.2 displays the entire 
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Figure 4.3. Hierarchical clustering of samples based on the Euclidean distance 
A. V segment gene usage of TCRαchain. B. J gene segment usage of TCRαchain.  
A B 
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Table 4.1. V&J gene usage in MS patients and Healthy controls 
TCRA MS Controls p.value 
TRAV12.3 0.029311 0.0169 0.021307 
TRAV13.1  0.075794 0.121643 0.049075 
TRAV27 0.029004 0.020036 0.052023 
TRAV38-2DV8 0.159797 0.108271 0.02268 
TRAV5 0.012193 0.021722 0.014338 
TRAJ11 0.009943 0.006756 0.042563 
TRAJ15 0.019014 0.009979 0.000728 
TRAJ17 0.014712 0.008432 0.014006 
TRAJ52 0.048084 0.024994 0.027462 
TRAJ6 0.021035 0.013237 0.018615 
 
4.4. Top20 sharing clonotypes between the MS patients and the healthy controls 
We selected the overlapping clonotypes of the TCRα CDR3 among all MS and 
healthy control samples. The top 20 clonotypes of the shared repertoire were processed 
with hierarchical analysis(Fig4.5.A). The semi-invariant T cell includes Mucosal-
associated invariant T cells(MAIT lymphocytes) and invariant natural killer T cell (iNK 
T cell). Dominant clonotypes among the top 20 include several that are associated with 
MAIT lymphocytes and iNK T cells. CAVRDSNYQLIW is shared between the most 
samples in our study; the controls had a significantly higher expression of this clonotype 
than MS patients (p= 0.05).  CAVRDSNYQLIW has have also been reported in rhesus 
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macaques, mice, as well as cattle[227, 228]. More importantly, CAVRDSNYQLIW is 
also found in multiple sclerosis pathologic brain lesions [229].CAVLDSNYQLIW 
expressed higher in the MS group (p=0.02) than healthy controls. 
CAVLDSNYQLIW（Fig4.5.B）has a higher level in the MS patient and shows  
BST2 specificity. CAVRDSNYQLIW is prevalent in most individuals and crosses the 
species barrier, and has specificity for the p65 of CMV antigen [230]. This corroborates 









Figure 4.5. A. Top20 overlap clonotype of CDR3 of TCR a chain between the MS and 
healthy controls. 
A. Top20 overlapping CDR3 of TCR a chain clonotypes between MS patients and 
healthy controls. B. Top20 overlapping CDR3clonotypes in MAIT cells in MS patients 
and healthy controls. 
B A 
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Figure 4.6. A. Phylogenetic tree of unique MAIT clonotypes of the CDR3 TCR a chain 
with antigen-specific annotation. B. CAVLDSNYQLIW has significantly higher 
expression in the MS group(t-test) .C.Wilcoxon test reconfirmed that CAVLDSNYQLIW 
has significantly higher expression in the MS group. 
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4.5. MAIT annotation  
MAIT lymphocyte function has been reported to be related to microbial infections 
[231-237]. Moreover, it also appears to play a role in autoimmune disease[57-60]. 
According to the molecular mimicry theory, there would be cross-reactivity between the 
self-antigen and the non-self antigen[238-240]. The recently published database VDJDB 
can be used in mapping antigen specificity by matching unknown CDR3s with previously 
published antigen-specific CDR3s [81]. Therefore, we annotated all the unique MAIT 
like clonotypes with all samples that matched with the database. The phylogenetic tree 
was constructed with the annotated CDR3. Annotated MAIT CDR3s show specificity to 
virus antigens from CMV[230], influenza[241], Yellow fever virus[242], as well as the 
self-antigen BST2[243]after matched with the VDJDB.   
4.6 MS associated CDR3 TCR-α repertoires  
Furthermore, we merged all the clonotypes of the MS patients with clonotypes of 
healthy controls. The frequency of each unique clonotype was tested with the Wilcoxon 
test.   Unique TCRA CDR3(P<0.05) having a higher level in MS patients were 
identified. To determine the function of MS associated CDR3s, the CDR3s were 
annotated by the VDJdb[81]. Clonotypes with HCV specificity were higher in the 
multiple sclerosis patient groups than the Healthy Control group. 
We annotated the TCRA CDR3 associated with multiple sclerosis with the 
VDJDB and found three clonotypes have previously identified antigen specific 
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information. As shown in table 2, CAVLDSNYQLIW which is a MAIT CDR3 shows 
BST2 specificity. CAVNTGNQFYF has cross-reactivity with CMV p65, influenza M1, 
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Figure 4.7.  MAIT cell CDR3 aa Sequence logo. 
A. Controls B. MS. C.Over expressed CDR3s in clonotypes. D.Over expressed CDR3s 
in MS clonotypes. E. CDR3 nucleotide logos of clonotypes. F. CDR3 nucleotide logos 
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Figure 4.8. MS Associated CDR3 of TCR a chain 
Figure 4.8.  A. Heatmap of MS associated clonotype in of CDR3 in TCR a chain.B.  
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Table 4.2.  MS Associated CDR3 Annotation  











TRAV1-2 TRAJ33 BST2 HomoSapiens https://github.com/antigenomics/vdjdb-db/issues/193 
CAVNTGNQFYF TRAV12-2 TRAJ49 p65 CMV PMID:28423320 
CAVNTGNQFYF TRAV12-2 TRAJ49 M1 InfluenzaA PMID:28636589 
CAVNTGNQFYF TRAV12-2 TRAJ49 BST2 HomoSapiens https://github.com/antigenomics/vdjdb-db/issues/193 
CAVSNTGNQFY
F 
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4.8. CDR3 TCR-α repertoire Annotation. 
To further explore the association of between the possible infectious disease 
clonotypes and auto-immune clonotypes, we annotated the CDR3 clonotypes in each. For 
most antigens including VP22 p65, NS4B, MLANA, M1, HA, and BST2 did not show a 
difference between multiple sclerosis patients and the healthy controls. However, we did 
find that the NS3-HCV specificity has a higher level in the multiple sclerosis patients 
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Heatmap of clonotype annotation of CDR3 TCR chains. B. statistical analysis of the 
specific CDR3s in MS and controls. 
Chapter III Summary 
In this chapter, the TCR α repertoire of MS patients and healthy controls were 
analyzed by NGS deep sequencing, filtering, and annotation,Consistent with the TCR 
βrepertoire, MS patients also showed a difference from healthy control subjects in the 








































































































































































































































 82  
Dr. Liu Yisu –T Cell Repertoire and Autoimmunity in Multiple Sclerosis Patients in Sardinia - International PhD Course in  Life Sciences and 
Biotechnologies– Microbiology and Immunology – University of Sassari, Italy 
 
clonotypes of the TCR αrepertoire. CDR3 length alterations of TCRA repertoire was 
observed in MS patients compared with the healthy controls. However, the coverage and 
the inserted nucleotides show no difference between the MS patients and the healthy 
controls. In the V&J gene usage, MS patients have a cluster that is distinguished from 
that of healthy controls.TRAV 12.3, TRAV27, TRAV38-2DV8, TRAV5as well as 
TRAJ11 TRAJ15 TRAJ17 TRAJ52 TRAJ6 shows significantly higher usage in MS 
patients. 
Mucosal-associated invariant T cell (MAIT lymphocytes) and invariant natural 
killer T cell (iNK T cell) are the dominant clonotypes among the top 20 sharing 
clonotypes between the MS patients and the healthy controls. Additional analysis of the 
clonotypes of MAIT among the TCR α repertoire showed that  CAVRDSNYQLIW is 
commonly shared between most of the samples in our study. CAVRDSNYQLIW shows 
specificity with p65 of CMV. CAVLDSNYQLIW is highly expressed in the MS cohort. 
CAVLDSNYQLIW shows a BST2 specificity. We further examined unique MAIT-like 
clonotypes among all TCRα repertoires for possible annotation. We found MAIT-like 
shows specificity to the virologic antigens including CMV, influenza, Yellow fever virus 
as well as the self-antigen BST2. 
MS associated CDR3 of TCR-α repertoires were also screened. After annotation 
CAVNTGNQFYF was found to be associated with withrecognizingCMVp65, influenza 
M1, and BST2. The clonotype CAVSNTGNQFYF also shows BST2 specificity. These 
results indicate cross specificity patterns may exist in T cell recognition and immunity. 
Also, we found that the NS3-HCV associated CDR3has a higher level in the multiple 
sclerosis patients than healthy controls.  
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Chapter V  
Discussion 
This is the first study to apply deep sequencing technology of the TCR repertoire 
in the Sardinians with multiple sclerosis. We found MS patients Sardinian origin present 
with a different TCR-β repertoire compared to the Sardinian healthy volunteers.  
Alterations in the length of TCRBV CDR3 was not observed in our MS patient cohort. 
According to our most recent analyses, diversity skew was not observed in our data. We 
found thatTRBV20-1 gene usage is high in the Sardinian population. We also found that 
TRBV20-1 J gene specific rearrangements were higher in the MS patients than healthy 
volunteers in Sardinia. 
Other studies have reported that T cell repertoire CDR3 length distribution 
skewing was observed in MS patients compared with healthy controls[244]. Lapland's 
work also indicated that the alterations of TCRBV CDR3 length correlated with the 
disease progression; however, our study did not find any obvious alteration in TCRBV 
CDR3 length in the TCRB gene of MS patients. The fact that all the MS patients in our 
study were in the chronic stage and the analysis was based on all TCRB genes may 
explain the differences between our observations and Lapland's work. Further analysis of 
specific TCRBV genes individually may give new insight into CDR3 length distribution.   
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 D gene insertion and the random nucleotide insertions and deletions in the VDJ 
region is another factor that could cause diversity and alter the CDR3 length of the TCR 
repertoire. Based on the analysis of the number of inserted random nucleotides between 
the MS patients and controls we have not found any significant variation of nucleotides in 
the CDR3 sequence. Since the analysis of the D gene and nucleotide insertions and 
deletions is highly dependent on the algorithms of the computational software used in our 
analysis investigation utilizing additional methods are needed to support our initial 
findings. 
It is believed that in MS patients, there is more clonal expansion and skewing in 
the TCR repertoire compared with the healthy population. Recent studies on NGS of the 
TCR repertoire in MS patients give new insights regarding this question.  Muraro et al.'s 
studies suggest higher TCR diversity after HSCT of the MS patient[245], while Shugay et 
al.’s study found lower diversity in MS samples compared with those of healthy controls 
and decreased diversity after HSCT in one MS patient[246]. Another NGS study has 
shown that the diversity of the TCRb repertoire is higher in the peripheral blood and 
cerebral spinal fluid (CSF) of MS patients compared with those of IIH(Idiopathic 
Intracranial Hypertension) controls[247]. Lossius et al. indicated that the TCR repertoire 
is high diverse in both the MS patients and the healthy controls, but EBV-specific CD8+ 
T cells were expanded in the CSF of MS patients. 
 So far, our result does not support the view that MS patients have a lower 
diversity of TCR repertoire in PBMCs compared with that of healthy controls. Generally, 
MS patients have the same level of diversity compared with that of controls, but the 
entropy of the repertoire diversity is higher in the MS patients.  Further studies could 
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determine whether these results are artifactual. Another factor that should be taken into 
consideration is that all the MS patients in our study were in the chronic stage of the 
disease, which is different from the acute relapsing stage used in other studies. 
Furthermore, 10 of our 13 MS patients were undergoing therapy, which may also have 
affected the diversity of MS patients. We are designing further studies concerning the 
effects of therapy on MS patient and TCR repertoire diversity.  
Our analysis showed a difference in the TCR-β repertoires of MS patients 
compared with those of healthy controls. The limited literature reported the TCR 
repertoire similarity or genetic distance between the MS and healthy control as the 
technical bottleneck as well as the suitable algorithm is not available. Marion 's work 
[248]  comparing individual CSF and PBMCs CD4+ T cells and CD8+ T cells, found 
that TCR Vb repertoire is shared between CNS lesions, CSF, and blood CD8+ T cells.  
This finding is different from previous ideas that the CSF and MS lesions are based on 
oligoclonal expansion. Shugay's work[246] did not find a significant distance between 
the MS group and the healthy controls, but within the MS group, the TCR repertoire 
showed a diffusion between the samples. The diffusion was also observed in our CDR3 
analysis, including that of the non-functional CDR3. Non-functional CDR3 is another 
important component thatshould be analyzed in the future. 
In MS repertoires previously studied,Vβ 5.2 usage was high in  MBP-specific T 
cells found by Kotzen al. in HLA-DR2 MS patients[203]. Vβ 5.2 was also r reported as 
significantly expanded in the blood of MS patients; moreover, Vβ 5.2 was most dominant 
in CSF and may be a target for immune therapy for MS[207, 249-252]. Our study, 
however, showed no-correlation of Vβ 5.2andMS patients in Sardinia. This result was 
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also found in other Vβ 5 family who reported has bias V gene usage in MS patient. In 
Shugay'sstudy TRBV genes, including TRBV5-6TRBV5-1, TRBV 5–8, TRBV 7–6, and 
TRBV20-1, are at a higher usage frequency in MS patients [246]. 
A study of the TCR repertoire of Sardinians revealed that the TCRBV20S1 null 
allele was significantly higher than in-Sardinian Caucasians[253, 254],but it did not 
indicate an increase in susceptibility to MS or type 1 diabetes (T1D) in the Sardinian 
population[255]. 
Analysis of the data in our study showed that e TRBV20-1(p-value=0.0792) has a 
higher frequency in the Sardinian population, but more data is needed to determine the 
significance of the null allele influence on the risk of multiple sclerosis. We found that 
the Variable-Joining segmentrearrangementTRBV20.1$TRBJ2.1(p=0.01223) and 
TRBV20.1$TRBJ1.5(p=0.00808951) showed a highly significant increase in the MS 
group. Furthermore, TRBV20.1$TRBJ2.1 is also dominant in screened MS associated 
with CDR3.TRBV20-1geneand was highly increased in MS patients in the Russian 
population[246]. The bias of the V gene usage could result in TCR repertoire skewing. 
Viral infection and autoimmune diseases, for instance, have been reported to have a TCR 
repertoire bias [256]; however, up until a point, we do not know what the was is the 
function of TRBV20.1 clonotypes. 
By comparing the EBV-specific TCR repertoire with the CSF and blood TCR 
repertoires, Andreas's group found that EBV-reactive CD8+ T cells expand in multiple 
sclerosis patients, indicating the important role of EBV infection in those patients [257].   
BMLF-1 is an early lytic protein expressed by EBV in the early lytic cycle. 
Increased BMLF-1 specific CD+8 T cells indicate either previous infection or viral 
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reactivation. The increased BMLF-1 associated CDR3 levels in MS patients give 
evidence in the TCR repertoire that EBV replication and activity maybe associated with 
the immunopathogenesis of MS. 
Although we found that BMLF-1 associated CDR3 is increased in the blood of 
MS patients, the correlation of the blood TCR repertoire with the CSF TCR repertoire as 
well as the infiltrated T cells in MS lesions was not determined in this study. Also, since 
this study recruited MS patients in the chronic stage, it may not explain how the 
autoimmune response is initiated or activated. A follow-up cohort study covering a 
longer period should be done to provide an immune repertoire of the patients at all stages 
of the disease, including before disease onset, first attack, relapse, and chronic stage. Our 
study would be the first step in defining this type of cohort. We have screened MS 
associated CDR3 sequences, but the function and phenotype should be determined in 
further studies. Single cell sequencing of the immune cell would provide a promising 
method to solve this problem. 
 
Generally, our TCR α repertoire results are in agreement with the TCR β 
repertoire analysis which indicates that MS patients show a difference from healthy 
control subjects in the clonotype of the TCR repertoire. In the V&J gene usage, MS 
patients have a cluster that is distinguished from that of healthy controls. The coverage 
and the number of inserted nucleotides show no difference between the MS patients and 
the healthy controls. 
Mucosal-associated invariant T lymphocytes (MAIT lymphocytes) are an innate-
like T cell with an invariant TCR α chain, and with highly conserved recombination with 
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TCRA1-2 and TCRJ33 in humans[56] MAIT cells have an antibiotic function that would 
be activated by some bacterial metabolites presented by the Major Classes of MHC Class 
I (MHC I)-Related Protein 1(MR1). Pro-inflammatory cytokines have also been reported 
as activators of the MAIT lymphocytes. 
MAIT lymphocytes have been demonstrated to be associated with autoimmune 
diseases[57-60], but their association with multiple sclerosis is still controversial. MAIT- 
like T cells with the clonotype of Va7.2‐Ja33 T cells were first found accumulated in a 
lesion of an MS patient[61]. It is important to determine the role MAIT plays in the MS 
pathogenesis:whether it has a standby role in the MS lesion or whether it protects the 
CNS from autoimmune injury, or even if it is a critical cell type that triggers 
autoimmunity. 
An EAE model was built to investigate unconventional T cell include MAIT 
function in MS pathological progression[258]. This study shows MAIT lymphocytes in 
mice could play a regulatory role in the of the immune system network. 
The role MAIT in human MS pathogenesis is still controversial as the frequency 
MAIT in the MS patients was found to be reduced compared with the healthy controls 
[204]. The author suggested that an immune-regulatory role of MAIT cells in MS through 
suppression of pathogenic T(h)1 cells was possible [259]. 
 Another study that was designed around a cohort of six pairs of twins did not 
show that MAIT CD8 T cells were increased in MS patients, indicating that MAIT has a 
pathogenetic feature in MS[260].  
Anautologoushematopoieticstem cell transplantation study with two years of follow-up 
post autologous hematopoietic stem cell transplantation (AHSCT) showed depleted 
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MAIT cells post transplantation[261], while a further study revealed antigen-driven 
MAIT expansion in the MS lesions by immunohistochemistry and PCR[262]. 
Recently it was further confirmed that the IL17+ MAIT cell was increased in MS 
patient peripheral blood[263]. 
In our study, we observed that there are several typical MAIT like 
cells,CAVRDSNYQLIW for example, which is widely found in most samples; however, 
some clonotypes show the higher levels in multiple sclerosis patients. 
While we may infer that MAIT is highly conserved among the population , there 
are some low-frequency MAIT cells that would show a difference between the healthy 
population and multiple sclerosis patients. Further large-cohort studies that can be 
validated by other molecular methods should confirm this. 
 These results pose the question regarding how those differences developed and 
what role MAIT cells play in multiple sclerosis disease progression.  
First, we may think about what role MR1 plays in MAIT development and 
immigration from the mucosa to other tissues. As we know MRI is highly conserved and 
expressed in most cell types.Whether there is a higher MR1 expression level in the CNS 
in multiple sclerosis remains to be seen. 
Secondly, the normal frequency of MAIT in different tissues as well as in 
peripheral blood should be determined. The increased frequency of certain clonotypes of 
MAIT in MS patients is maybe caused by the circulating pathogenetic T cell expansion of 
that clonotype. 
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Third, as an important component of mucosal immunity, MAIT cells inevitably 
affect gut microbes. Correspondingly, the microbes react to the clonotype diversity of 
MAIT and come to a symbiotic balance. 
Last, the fact that CMV and EBV belong to the HSV family and have a very high 
prevalence and long latent infection period the humans could also be a factor in the 
changes in the clonotypes of T cells and B cells.  
With TCR annotation, some MAIT CDR3 shows specificity to virologic antigens 
including CMV, influenza, yellow fever virus, and HCV as well as self-antigens such as 
BST2. 
Although the available CDR3 is limited in VDJDB and affect the annotation data 
output, the annotation data of the MAIT CDR3 in our study is provocative leading to the 
obvious question of the role of MAIT cells in regulating viral infections and 
autoimmunity. 
To determine the antigen specificity of MAIT cells with different clonotypes, it is 
important first to understand the function of the MAIT cells. We matched MAIT cell 
CDR3 with previously published CDR3 and found several hits. Most antigens, including 
VP22 p65 NS4B, MLANA,M1 HA, and BST2, did not show any differences between 
multiple sclerosis patients and the healthy control subjects; however, we did find that 
NS3-HCVshowedhigher levels in multiple sclerosis patients.  
In conclusion, we found that MS patients present a TCRβ repertoire that can be 
distinguished from the healthy controls in the Sardinian population. BMLF-1 associated 
CDR3 are screened out in the MS associated CDR3, indicating a higher activity of EBV 
in MS patients. TRBV20.1, especially when rearranged with TRBJ2.1, TRBJ1.5 are in 
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high usage in the Sardinian population. These are ample data from our study suggesting 
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